Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

(2015) Anita Kohli et al.   LANCET

Delivery of treatment for hepatitis C virus infection in the primary care setting

(2014) David Baker et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

HIV infection: epidemiology, pathogenesis, treatment, and prevention

(2014) Gary Maartens et al.   LANCET

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

(2014) Eric Lawitz et al.   LANCET

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

(2014) Peter Ferenci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C can be cured globally, but at what cost?

(2014) A. Hill et al.   SCIENCE

The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis

(2013) Yousra A Mohamoud et al.   BMC INFECTIOUS DISEASES

A Canadian screening program for hepatitis C: Is now the time?

(2013) H. A. Shah et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Enhancing Assessment and Treatment of Hepatitis C in the Custodial Setting

(2013) Jeffrey J. Post et al.   CLINICAL INFECTIOUS DISEASES

Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study

(2013) Maryam Alavi et al.   CLINICAL INFECTIOUS DISEASES

Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels

(2013) Jason Grebely et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

Overcoming Barriers to Care for Hepatitis C

(2012) Paul J. Clark et al.   NEW ENGLAND JOURNAL OF MEDICINE

New direct-acting antivirals' combination for the treatment of chronic hepatitis C

(2011) Tarik Asselah et al.   LIVER INTERNATIONAL

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

(2011) Sanjeev Arora et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing

(2010) Wendy S.C. Cheng et al.   JOURNAL OF HEPATOLOGY

Curing hepatitis C with pills: a step toward global control

(2010) David L Thomas   LANCET

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users

(2007) Jason Grebely et al.   DRUG AND ALCOHOL DEPENDENCE